Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

Market Cap	27.44M
Revenue (ttm)	6.67M -24.8%
Net Income	-1.25M
EPS	-0.01
Shares Out	137.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,800
Average Volume	77,185
Open	0.2000
Previous Close	0.2000
Day's Range	0.2000 - 0.2000
52-Week Range	0.1450 - 0.3450
Beta	0.02
RSI	48.40
Earnings Date	Feb 27, 2026

About KLSE:MGRC

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. Its flagship product, Dtect genetic screening tests which inspects DNA for markers associated with genetic variations that influence various biological processes. The company also offers genome sequencing services for humans, animals, plants, and microbes and other living organisms; transcriptome sequencing; and metagenomics and metatranscriptomics. In addition, it provides genome analy...

• Industry: Commercial Physical and Biological Research
• Founded: 2004
• Employees: 16
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: MGRC

Financial Performance

In 2024, KLSE:MGRC's revenue was 5.52 million, a decrease of -42.32% compared to the previous year's 9.57 million. Losses were -4.19 million, -78.00% less than in 2023.